Throughout Friday’s buying and selling session, the shares of a number one supplier of design, engineering and electronics manufacturing companies (EMS) surged practically 2.5 p.c on NSE, after securing a purchase order order price Rs. 53.7 crores for the provision of PCBA (Printed Circuit Board Meeting).
Worth Motion
With a market capitalisation of Rs. 845.8 crores, the shares of Vinyas Modern Applied sciences Restricted moved up by practically 2.5 p.c to hit an intraday excessive at Rs. 694 on NSE, as towards its earlier closing value of Rs. 677.
What’s the Information
Vinyas Modern Applied sciences Restricted has introduced receiving buy orders from numerous undisclosed home & worldwide prospects price Rs. 53.74 crores for the manufacture and provide of PCBA (Printed Circuit Board Meeting) which is scheduled to be executed in 24 months.
Earlier Orders
twenty third December 2024: Vinyas Modern Applied sciences bagged an order price Rs. 390 crores from an undisclosed home buyer.
sixth February 2025: The corporate secured an order price Rs. 89.25 crores from Alpha Design Applied sciences Pvt Ltd and numerous different Home & worldwide Clients for the manufacture and provide of PCBA and digital assemblies.
Additionally learn: Midcap inventory in focus after saying ₹900 Cr capex plan for hospital in Kolkata
Financials
Vinyas Modern Applied sciences reported a marginal progress in its income from operations, exhibiting a year-on-year rise of 9.5 p.c from Rs. 137 crores in H1 FY24 to Rs. 150 crores in H1 FY25.
Equally, its web revenue elevated throughout the identical interval from Rs. 6 crores to Rs. 7 crores, indicating a slight progress of round 16.7 p.c YoY.
Concerning the Firm
Included in 2001, Vinyas Modern Applied sciences Restricted is engaged within the enterprise of offering design, engineering and electronics manufacturing companies (EMS) catering to world Authentic Gear Producers (OEMs) and Authentic Design Producers (ODMs) within the Digital Trade.
Written by Shivani Singh
Disclaimer
The views and funding ideas expressed by funding consultants/broking homes/ranking companies on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a danger of economic losses. Buyers should due to this fact train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the creator will not be responsible for any losses prompted because of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
